AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Selling Secrets Across The Globe
Motley Fool Money
CRISPR Therapeutics and the Risk of Failure
2min Snip
00:00
Summary
Transcript
Episode notes
Some of their more advanced stage pipeline development programs actually are with CRISPR. So they're trying to develop one-time treatments here that focus on the partnership withCRISPR specifically towards blood disorders, sickle cell disease, and beta thalassemia. Right now those studies are ongoing in phase three, which as I mentioned is one of the later stages. But they have already filed their biologics license applications to the FDA, including a request for priority review.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode